Physician profile
Daniel S Malach
NPI 1487003612
$4,463.18
in general payments reported to CMS, 2019-2025
22 companies · $580 in 2025
The $580 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,672 · 2020: $167 · 2021: $57.17 · 2022: $349 · 2023: $1,068 · 2024: $570 · 2025: $580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,581.81 | 2019-2025 | Rocklatan, Rhopressa, Simbrinza |
| Bausch & Lomb Americas INC. | $624.83 | 2022-2025 | Miebo, Vyzulta, Envista Mx60 Iol |
| Regeneron Healthcare Solutions, INC. | $380.42 | 2019-2025 | Eylea Hd, Eylea |
| Glaukos Corporation | $270.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $261.13 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $215.30 | 2023-2025 | Cequa |
| Rxsight INC | $181.68 | 2021-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $175.03 | 2019-2024 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $142.92 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $126.34 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $114.85 | 2019 | |
| New World Medical,INC. | $108.13 | 2022 | |
| Dompe US, INC. | $69.06 | 2022-2025 | Oxervate |
| Harrow Eye, LLC | $39.51 | 2023-2025 | Vevye, Iheezo |
| Carl Zeiss Meditec, INC. | $36.11 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $33.76 | 2022-2023 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Genentech USA, INC. | $19.77 | 2024 | Vabysmo |
| Oyster Point Pharma, INC. | $18.19 | 2024 | Tyrvaya |
| Biotissue Holdings INC. | $17.93 | 2023 | |
| Sight Sciences, INC. | $16.34 | 2025 | Omni Surgical System |
| Ocular Therapeutix, INC. | $15.24 | 2021 | |
| Eyevance Pharmaceuticals LLC | $14.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Malach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.